Cytokinetics Stock Market Sentiment

CYTK
 Stock
  

USD 48.74  1.44  3.04%   

Cytokinetics investor sentiment overview provides quick insight into current market opportunities from investing in Cytokinetics. The current market sentiment together Cytokinetics' historical and current headlines can help investors to time the market. Many technical investors use Cytokinetics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Cytokinetics Hype Analysis, Cytokinetics Correlation and Cytokinetics Performance.
  
Refresh
Cytokinetics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Cytokinetics daily returns and investor perception about the current pice of Cytokinetics as well as its diversification or hedging effects on your existing portfolios.

Cytokinetics Latest Sentiment Indicators

200 Day MA
37.66
Short Percent
0.15
Short Ratio
9.37
Shares Short Prior Month
8.7 M
50 Day MA
39.84
52 Week Low
17.72
Shares Short
8.5 M

Cytokinetics Current Investor Sentiment

Investor biases related to Cytokinetics' public news can be used to forecast risks associated with investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Cytokinetics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cytokinetics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cytokinetics' news discussions. The higher the estimate score, the more favorable is the investor's outlook on Cytokinetics.

Cytokinetics Maximum Pain Price across 2022-07-15 Option Contracts

Cytokinetics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Cytokinetics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Cytokinetics' options.
few days ago at www.gurufocus.com         
Cytokinetics Hopes to Emulate Vertexs Market Success, Share Price Gains - GuruFocus.com
Gurufocus Stories at Macroaxis
over a week ago at www.gurufocus.com         
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 - GuruFocus.com
Gurufocus Stories at Macroaxis
over a week ago at www.gurufocus.com         
Exercise or conversion by Robert Blum of 10000 shares of Cytokinetics subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a week ago at www.gurufocus.com         
Cytokinetics Announces Three Upcoming Presentations at the European Society of Cardiology Heart Fail...
Gurufocus Stories at Macroaxis
over two weeks ago at www.macroaxis.com         
Exercise or conversion by Fady Malik of 21500 shares of Cytokinetics subject to Rule 16b-3
Macroaxis News
over two weeks ago at www.macroaxis.com         
Exercise or conversion by Robert Blum of 10000 shares of Cytokinetics subject to Rule 16b-3
Macroaxis News
over three weeks ago at www.marketscreener.com         
Cytokinetics Announces Additional Results From REDWOOD-HCM to Be Presented at the American Society o...
news
over three weeks ago at stockhouse.com         
2022-06-02 NDAQCYTK Press Release Cytokinetics Incorporated - Stockhouse
news
over three weeks ago at www.fiercebiotech.com         
Amgens heart drug reduces cardiovascular disease risk factor in phase 2 trial - FierceBiotech
news
over a month ago at www.defenseworld.net         
Cytokinetics, Incorporated Receives Consensus Recommendation of Buy from Brokerages - Defense World
news
over a month ago at www.defenseworld.net         
Cytokinetics Buy Rating Reiterated at HC Wainwright - Defense World
news
over a month ago at www.marketscreener.com         
Cytokinetics Announces Data From REDWOOD-HCM OLE and GALACTIC-HF Presented as Late Breaking Science ...
news
over a month ago at www.macroaxis.com         
Exercise or conversion by Robert Blum of 10000 shares of Cytokinetics subject to Rule 16b-3
Macroaxis News
over a month ago at www.benzinga.com         
Cytokinetics to Participate in the 2022 H.C. Wainwright Global Life Sciences Conference - Benzinga -...
benzinga news
over a month ago at www.marketscreener.com         
Cytokinetics Announces Three Upcoming Presentations at the European Society of Cardiology Heart Fail...
news
There is far too much social signal, news, headlines, and media speculation about Cytokinetics that is available to investors today. That information is available publicly through Cytokinetics media outlets and privately through word of mouth or via Cytokinetics internal channels. However, regardless of the origin, that massive amount of Cytokinetics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cytokinetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cytokinetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cytokinetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cytokinetics alpha.

Cytokinetics Performance against DOW

 Price Growth (%)  
      Timeline 
1
Financial Statements04/01/2022
2
Other04/04/2022
3
Exercise or conversion by Ching Jaw of 10000 shares of Cytok...04/06/2022
4
Exercise or conversion by Fady Malik of 23148 shares of Cyto...04/07/2022
5
Filing04/08/2022
6
Filing04/12/2022
7
Acquisition by Harrington Robert Arthur of 35000 shares of C...04/18/2022
8
Cytokinetics to Announce First Quarter Results on May 4, 202...04/20/2022
9
Exercise or conversion by Robert Blum of 10000 shares of Cyt...04/22/2022
10
Cytokinetics Given New 75.00 Price Target at HC Wainwright -...04/29/2022
11
Cytokinetics to Hold Annual Meeting of Stockholders - Benzin...05/03/2022
12
EPS Reported05/04/2022
13
Exercise or conversion by Robert Blum of 10000 shares of Cyt...05/06/2022
14
What You Need To Know About The Cytokinetics, Incorporated A...05/09/2022
15
Acquisition by Harrington Robert Arthur of 10000 shares of C...05/11/2022
16
Exercise or conversion by Fady Malik of 13987 shares of Cyto...05/12/2022
17
Other05/17/2022
18
Exercise or conversion by Robert Blum of 10000 shares of Cyt...05/18/2022
19
Other05/23/2022
20
Filing05/27/2022
21
Cytokinetics Announces Additional Results From REDWOOD-HCM t...06/03/2022
22
Exercise or conversion by Robert Blum of 10000 shares of Cyt...06/08/2022
23
Exercise or conversion by Fady Malik of 21500 shares of Cyto...06/10/2022
24
Other06/13/2022
25
Cytokinetics Announces Three Upcoming Presentations at the E...06/15/2022
26
Other06/16/2022
27
Other06/17/2022
28
Cytokinetics Hopes to Emulate Vertexs Market Success, Share ...06/23/2022
Continue to Cytokinetics Hype Analysis, Cytokinetics Correlation and Cytokinetics Performance. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.2 B
Quarterly Revenue Growth YOY
-0.82
Return On Assets
-0.19
Return On Equity
-2.8
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.